Checkpoint Therapeutics Q1 EPS $(0.33) Misses $(0.27) Estimate
Checkpoint Therapeutics Q1 EPS $(0.33) Misses $(0.27) Estimate
Checkpoint Therapeutics第一季度每股收益美元（0.33美元）未達到預期（0.27美元）
Checkpoint Therapeutics (NASDAQ:CKPT) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 62.92 percent increase over losses of $(0.89) per share from the same period last year.
Checkpoint Therapeutics（納斯達克股票代碼：CKPT）公佈的季度虧損爲每股0.33美元，比分析師普遍預期的0.27美元（0.27美元）低22.22％。與去年同期每股虧損0.89美元（0.89）相比，增長了62.92％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。